Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study (2022)

First Author: Sirijatuphat R

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/22221751.2022.2117092

PubMed Identifier: 35997325

Publication URI: http://europepmc.org/abstract/MED/35997325

Type: Journal Article/Review

Parent Publication: Emerging Microbes & Infections

Issue: 1

ISSN: 2222-1751